# The Study To Test The Effect of Standardization Of Fluid Intake In Female Patients With Overactive Bladder

> **NCT00553657** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 55 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** DETROL LA (drug)

## Key facts

- **NCT ID:** NCT00553657
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2010-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00553657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00553657, "The Study To Test The Effect of Standardization Of Fluid Intake In Female Patients With Overactive Bladder". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00553657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*